vs
EAGLE MATERIALS INC(EXP)与百利高(PRGO)财务数据对比。点击上方公司名可切换其他公司
百利高的季度营收约是EAGLE MATERIALS INC的2.0倍($1.1B vs $556.0M),EAGLE MATERIALS INC净利率更高(18.5% vs -127.8%,领先146.3%),EAGLE MATERIALS INC同比增速更快(-0.4% vs -2.5%),百利高自由现金流更多($148.6M vs $60.8M),过去两年EAGLE MATERIALS INC的营收复合增速更高(8.0% vs 1.3%)
Eagle Materials Inc.是总部位于美国得克萨斯州达拉斯的建筑材料生产企业,主营产品包括水泥、混凝土、建筑骨料、石膏、墙板、纸板以及水力压裂作业专用砂,产品广泛应用于建筑施工、能源开发等多个领域。
百利高(Perrigo)是一家注册于爱尔兰的非处方仿制药生产商,主打自有品牌OTC药品业务。公司70%的净销售额来自美国医疗市场,为优化税务布局将法定总部设在爱尔兰,该地区销售额仅占总营收的0.6%,2013年曾完成美国历史上第六大企业税收倒置交易。
EXP vs PRGO — 直观对比
营收规模更大
PRGO
是对方的2.0倍
$556.0M
营收增速更快
EXP
高出2.2%
-2.5%
净利率更高
EXP
高出146.3%
-127.8%
自由现金流更多
PRGO
多$87.8M
$60.8M
两年增速更快
EXP
近两年复合增速
1.3%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $556.0M | $1.1B |
| 净利润 | $102.9M | $-1.4B |
| 毛利率 | 28.9% | 32.6% |
| 营业利润率 | — | -116.0% |
| 净利率 | 18.5% | -127.8% |
| 营收同比 | -0.4% | -2.5% |
| 净利润同比 | -13.9% | -3093.9% |
| 每股收益(稀释后) | $3.22 | $-10.23 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
EXP
PRGO
| Q4 25 | $556.0M | $1.1B | ||
| Q3 25 | $638.9M | $1.0B | ||
| Q2 25 | $634.7M | $1.1B | ||
| Q1 25 | $470.2M | $1.0B | ||
| Q4 24 | $558.0M | $1.1B | ||
| Q3 24 | $623.6M | $1.1B | ||
| Q2 24 | $608.7M | $1.1B | ||
| Q1 24 | $476.7M | $1.1B |
净利润
EXP
PRGO
| Q4 25 | $102.9M | $-1.4B | ||
| Q3 25 | $137.4M | $7.5M | ||
| Q2 25 | $123.4M | $-8.4M | ||
| Q1 25 | $66.5M | $-6.4M | ||
| Q4 24 | $119.6M | $-44.4M | ||
| Q3 24 | $143.5M | $-21.0M | ||
| Q2 24 | $133.8M | $-108.4M | ||
| Q1 24 | $77.1M | $2.0M |
毛利率
EXP
PRGO
| Q4 25 | 28.9% | 32.6% | ||
| Q3 25 | 31.3% | 36.1% | ||
| Q2 25 | 29.2% | 34.4% | ||
| Q1 25 | 22.2% | 37.6% | ||
| Q4 24 | 31.9% | 33.9% | ||
| Q3 24 | 32.7% | 37.2% | ||
| Q2 24 | 30.7% | 37.0% | ||
| Q1 24 | 25.1% | 33.1% |
营业利润率
EXP
PRGO
| Q4 25 | — | -116.0% | ||
| Q3 25 | — | 7.0% | ||
| Q2 25 | — | 4.3% | ||
| Q1 25 | — | 4.5% | ||
| Q4 24 | 32.8% | 10.0% | ||
| Q3 24 | 34.2% | 7.4% | ||
| Q2 24 | 32.0% | -2.5% | ||
| Q1 24 | 26.9% | -5.1% |
净利率
EXP
PRGO
| Q4 25 | 18.5% | -127.8% | ||
| Q3 25 | 21.5% | 0.7% | ||
| Q2 25 | 19.4% | -0.8% | ||
| Q1 25 | 14.1% | -0.6% | ||
| Q4 24 | 21.4% | -3.9% | ||
| Q3 24 | 23.0% | -1.9% | ||
| Q2 24 | 22.0% | -10.2% | ||
| Q1 24 | 16.2% | 0.2% |
每股收益(稀释后)
EXP
PRGO
| Q4 25 | $3.22 | $-10.23 | ||
| Q3 25 | $4.23 | $0.05 | ||
| Q2 25 | $3.76 | $-0.06 | ||
| Q1 25 | $2.01 | $-0.05 | ||
| Q4 24 | $3.56 | $-0.32 | ||
| Q3 24 | $4.26 | $-0.15 | ||
| Q2 24 | $3.94 | $-0.79 | ||
| Q1 24 | $2.23 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $419.0M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.5B | $2.9B |
| 总资产 | $3.8B | $8.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
EXP
PRGO
| Q4 25 | $419.0M | — | ||
| Q3 25 | $35.0M | $432.1M | ||
| Q2 25 | $59.7M | $454.2M | ||
| Q1 25 | $20.4M | $409.9M | ||
| Q4 24 | $31.2M | $558.8M | ||
| Q3 24 | $93.9M | $1.5B | ||
| Q2 24 | $46.5M | $542.8M | ||
| Q1 24 | $34.9M | $658.5M |
总债务
EXP
PRGO
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $1.2B | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $1.1B | — |
股东权益
EXP
PRGO
| Q4 25 | $1.5B | $2.9B | ||
| Q3 25 | $1.5B | $4.4B | ||
| Q2 25 | $1.5B | $4.5B | ||
| Q1 25 | $1.5B | $4.4B | ||
| Q4 24 | $1.5B | $4.3B | ||
| Q3 24 | $1.4B | $4.6B | ||
| Q2 24 | $1.4B | $4.5B | ||
| Q1 24 | $1.3B | $4.7B |
总资产
EXP
PRGO
| Q4 25 | $3.8B | $8.5B | ||
| Q3 25 | $3.4B | $10.1B | ||
| Q2 25 | $3.4B | $10.1B | ||
| Q1 25 | $3.3B | $9.8B | ||
| Q4 24 | $3.0B | $9.6B | ||
| Q3 24 | $3.1B | $11.2B | ||
| Q2 24 | $3.0B | $10.4B | ||
| Q1 24 | $2.9B | $10.6B |
负债/权益比
EXP
PRGO
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.86× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.84× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $170.8M | $175.4M |
| 自由现金流经营现金流 - 资本支出 | $60.8M | $148.6M |
| 自由现金流率自由现金流/营收 | 10.9% | 13.4% |
| 资本支出强度资本支出/营收 | 19.8% | 2.4% |
| 现金转化率经营现金流/净利润 | 1.66× | — |
| 过去12个月自由现金流最近4个季度 | $231.8M | $145.1M |
8季度趋势,按日历期对齐
经营现金流
EXP
PRGO
| Q4 25 | $170.8M | $175.4M | ||
| Q3 25 | $204.6M | $51.7M | ||
| Q2 25 | $136.6M | $75.9M | ||
| Q1 25 | $62.8M | $-64.5M | ||
| Q4 24 | $119.9M | $312.6M | ||
| Q3 24 | $233.3M | $42.2M | ||
| Q2 24 | $132.6M | $9.5M | ||
| Q1 24 | $63.4M | $-1.4M |
自由现金流
EXP
PRGO
| Q4 25 | $60.8M | $148.6M | ||
| Q3 25 | $96.1M | $29.8M | ||
| Q2 25 | $60.5M | $56.7M | ||
| Q1 25 | $14.5M | $-90.0M | ||
| Q4 24 | $72.5M | $274.9M | ||
| Q3 24 | $166.8M | $15.1M | ||
| Q2 24 | $99.5M | $-18.9M | ||
| Q1 24 | $30.9M | $-26.5M |
自由现金流率
EXP
PRGO
| Q4 25 | 10.9% | 13.4% | ||
| Q3 25 | 15.0% | 2.9% | ||
| Q2 25 | 9.5% | 5.4% | ||
| Q1 25 | 3.1% | -8.6% | ||
| Q4 24 | 13.0% | 24.2% | ||
| Q3 24 | 26.7% | 1.4% | ||
| Q2 24 | 16.3% | -1.8% | ||
| Q1 24 | 6.5% | -2.4% |
资本支出强度
EXP
PRGO
| Q4 25 | 19.8% | 2.4% | ||
| Q3 25 | 17.0% | 2.1% | ||
| Q2 25 | 12.0% | 1.8% | ||
| Q1 25 | 10.3% | 2.4% | ||
| Q4 24 | 8.5% | 3.3% | ||
| Q3 24 | 10.7% | 2.5% | ||
| Q2 24 | 5.4% | 2.7% | ||
| Q1 24 | 6.8% | 2.3% |
现金转化率
EXP
PRGO
| Q4 25 | 1.66× | — | ||
| Q3 25 | 1.49× | 6.89× | ||
| Q2 25 | 1.11× | — | ||
| Q1 25 | 0.94× | — | ||
| Q4 24 | 1.00× | — | ||
| Q3 24 | 1.63× | — | ||
| Q2 24 | 0.99× | — | ||
| Q1 24 | 0.82× | -0.70× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EXP
| External Customers | $283.5M | 51% |
| Gypsum Wallboard | $175.9M | 32% |
| Recycled Paperboard | $47.8M | 9% |
| Corporate Joint Venture | $29.4M | 5% |
| Other | $11.8M | 2% |
| Western Pennsylvania Acquisition | $7.6M | 1% |
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |